Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01358864
Brief Title: Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

First Submitted : May 23, 2011
First Submitted that Met QC Criteria : May 23, 2011
First Posted : May 24, 2011 (Estimate)

Results First Submitted : July 3, 2015
Results First Submitted that Met QC Criteria : September 22, 2015
Results First Posted : October 28, 2015 (Estimate)

Certification/Extension First Submitted : April 30, 2014
Certification/Extension First Submitted that Met QC Criteria : May 19, 2014
Certification/Extension First Posted : May 29, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 28, 2016
Last Update Posted : August 29, 2016 (Estimate)